Assignee
CONNAUGHT LAB
US147 patents
Top patents by PatentIndex Score
US6291157B1Sep 18, 2001
Antigenically-marked non-infectious retrovirus-like particles
CONNAUGHT LAB48 citations96
US6225091B1May 1, 2001
Multimeric hybrid gene encoding a chimeric protein which confers protection against parainfluenza virus and respiratory synctial virus
CONNAUGHT LAB27 citations96
US6080408AJun 27, 2000
Human immunodeficiency virus type 1 nucleic acids devoid of long terminal repeats capable of encoding for non-infectious, immunogenic, retrovirus-like particles
CONNAUGHT LAB67 citations96
US6025125AFeb 15, 2000
Methods for the detection of HIV-specific immune responses employing non-infectious, non-replicating, IIV retrovirus-like particles containing heterologous antigenic markers
CONNAUGHT LAB42 citations96
US5985641ANov 16, 1999
Non-infectious, replication-impaired, immunogenic human immunodeficiency virus type 1 retrovirus-like particles with multiple genetic deficiencies
CONNAUGHT LAB32 citations96
US5968776AOct 19, 1999
Multimeric hybrid gene encoding a chimeric protein which confers protection against parainfluenza virus and respiratory syncytial virus
CONNAUGHT LAB28 citations96
US5965714AOct 12, 1999
Method for the covalent attachment of polysaccharides to protein molecules
CONNAUGHT LAB142 citations96
US5955342ASep 21, 1999
Non-infectious, replication-defective, self-assembling HIV-1 viral particles containing antigenic markers in the gag coding region
CONNAUGHT LAB51 citations96
US5889176AMar 30, 1999
Nucleic acid molecules encoding non-infectious, non-replicating, HIV retrovirus-like particles containing heterologous antigenic anchor sequences
CONNAUGHT LAB35 citations96
US5879925AMar 9, 1999
Genetically engineered human immunodeficiency virus-like particles with modified chimeric envelope glycoproteins containing influenza virus transmembrane spanning domains
CONNAUGHT LAB45 citations96
US5876731AMar 2, 1999
Tandem synthetic HIV-1 Peptides
CONNAUGHT LAB47 citations96
US5866320AFeb 2, 1999
Nucleic acids encoding for non-infectious, replication-defective, self-assembling HIV-1 viral particles containing antigenic markers in the gag coding region
CONNAUGHT LAB45 citations96
US5808024ASep 15, 1998
Nucleic acids encoding high molecular weight major outer membrane protein of moraxella
CONNAUGHT LAB36 citations96
US5800822ASep 1, 1998
Tandem synthetic HIV-1 peptides
CONNAUGHT LAB29 citations96
US5759769AJun 2, 1998
Tandem synthetic HIV-1 peptides
CONNAUGHT LAB54 citations96
US5639854AJun 17, 1997
Tandem synthetic HIV-1 peptides
CONNAUGHT LAB36 citations96
US4806355AFeb 21, 1989
Microencapsulation of living tissue and cells
CONNAUGHT LAB212 citations96
US4689293AAug 25, 1987
Microencapsulation of living tissue and cells
CONNAUGHT LAB163 citations96
US4673566AJun 16, 1987
Microencapsulation of living tissue and cells
CONNAUGHT LAB236 citations96
US5085862AFeb 4, 1992
Genetic detoxification of pertussis toxin
CONNAUGHT LAB83 citations95
US6235523B1May 22, 2001
Vectors for DNA immunization against cervical cancer
CONNAUGHT LAB64 citations94
US6060308AMay 9, 2000
RNA respiratory syncytial virus vaccines
CONNAUGHT LAB74 citations94
US6019980AFeb 1, 2000
Nucleic acid respiratory syncytial virus vaccines
CONNAUGHT LAB39 citations94
US5853736ADec 29, 1998
Potentiation of immunogenic response
CONNAUGHT LAB39 citations94
US5686078ANov 11, 1997
Primary and secondary immunization with different physio-chemical forms of antigen
CONNAUGHT LAB48 citations94
US5681570AOct 28, 1997
Immunogenic conjugate molecules
CONNAUGHT LAB83 citations94
US5679352AOct 21, 1997
Synthetic Haemophilus influenzae conjugate vaccine
CONNAUGHT LAB94 citations94
US5571712ANov 5, 1996
Non-infectious, replication defective, immunogenic HIV retrovirus-like particles produced from a recombinant HIV genome devoid of long terminal repeats
CONNAUGHT LAB29 citations94
US5439809AAug 8, 1995
Non-infectious HIV particles lacking long terminal repeats
CONNAUGHT LAB53 citations94
US4956128ASep 11, 1990
Droplet generation
CONNAUGHT LAB71 citations94
US4492684AJan 8, 1985
Slow release injectable insulin composition
CONNAUGHT LAB132 citations94
US6147057ANov 14, 2000
Analog of Haemophilus Hin47 with reduced protease activity
CONNAUGHT LAB17 citations93
US6114125ASep 5, 2000
Analog of Haemophilus Hin47 with reduced protease activity
CONNAUGHT LAB17 citations93
US6025342AFeb 15, 2000
Analog of Haemophilus Hin47 with reduced protease activity
CONNAUGHT LAB19 citations93
US5981503ANov 9, 1999
Analog of Haemophilus Hin47 with reduced protease activity
CONNAUGHT LAB19 citations93
US5939297AAug 17, 1999
Analog of haemophilus HIN47 with reduced protease activity
CONNAUGHT LAB20 citations93
US5935573AAug 10, 1999
Method of use of an analog of Haemophilus influenzae Hin47 with reduced protease activity
CONNAUGHT LAB19 citations93
US5869302AFeb 9, 1999
Analog of haemophilus hin47 with reduced protease activity
CONNAUGHT LAB21 citations93
US5656436AAug 12, 1997
Analog of Haemophilus Hin47 with reduced protease activity
CONNAUGHT LAB20 citations93
US5506139AApr 9, 1996
Analog of haemophilus Hin47 with reduced protease activity
CONNAUGHT LAB27 citations93
US6228423B1May 8, 2001
Biodegradable targetable microparticle delivery system
CONNAUGHT LAB15 citations92
US6121021ASep 19, 2000
Constitutive expression of non-infectious HIV-like particles
CONNAUGHT LAB23 citations92
US6083925AJul 4, 2000
Nucleic acid respiratory syncytial virus vaccines
CONNAUGHT LAB29 citations92
US6080589AJun 27, 2000
Neisseria meningitidis capsular polysacchride conjugates
CONNAUGHT LAB16 citations92
US6018022AJan 25, 2000
Modification of pertussis toxin
CONNAUGHT LAB16 citations92
US6017539AJan 25, 2000
Chimeric protein which confers protection against parainfluenza virus and respiratory syncytial virus
CONNAUGHT LAB16 citations92
US5977304ANov 2, 1999
Modification of pertussis toxin
CONNAUGHT LAB17 citations92
US5965385AOct 12, 1999
Modification of pertussis toxin
CONNAUGHT LAB20 citations92
US5951986ASep 14, 1999
Tandem synthetic HIV-1 peptides
CONNAUGHT LAB18 citations92
US5866137AFeb 2, 1999
Self-assembled, non-infectious, non-replicating; immunogenic retrovirus-like particles comprising modified HIV genomes devoid of long terminal repeats and chimeric envelope glycoproteins
CONNAUGHT LAB17 citations92
Showing the top 50 of 147 patents by PatentIndex Score.